These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
452 related items for PubMed ID: 20630662
1. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R. Pathol Res Pract; 2010 Sep 15; 206(9):616-24. PubMed ID: 20630662 [Abstract] [Full Text] [Related]
6. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis. Gushima M, Hirahashi M, Matsumoto T, Fujita K, Ohuchida K, Oda Y, Yao T, Iida M, Tsuneyoshi M. Histopathology; 2011 Sep 15; 59(3):460-9. PubMed ID: 22034886 [Abstract] [Full Text] [Related]
7. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D. Laryngoscope; 2005 Aug 15; 115(8):1395-401. PubMed ID: 16094112 [Abstract] [Full Text] [Related]
8. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma. Liu XF, Kong FM, Xu Z, Yu SP, Sun FB, Zhang CS, Huang QX, Zhou XT, Song ZW. Hepatobiliary Pancreat Dis Int; 2007 Aug 15; 6(4):407-11. PubMed ID: 17690039 [Abstract] [Full Text] [Related]
9. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer. Sugita H, Iida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, Takagi Y, Enjoji M, Yamada H, Uetake H, Kojima K, Sugihara K. Oncol Rep; 2011 Feb 15; 25(2):513-8. PubMed ID: 21152877 [Abstract] [Full Text] [Related]
10. Aberrant methylation of the Pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis. Okada S, Suzuki K, Takaharu K, Noda H, Kamiyama H, Maeda T, Saito M, Koizumi K, Miyaki Y, Konishi F. Int J Oncol; 2012 Mar 15; 40(3):686-94. PubMed ID: 22002136 [Abstract] [Full Text] [Related]
11. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Brabender J, Arbab D, Huan X, Vallböhmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R. Ann Surg Oncol; 2009 May 15; 16(5):1378-83. PubMed ID: 19224282 [Abstract] [Full Text] [Related]
12. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC. Scarpa M, Scarpa M, Castagliuolo I, Erroi F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I, Castoro C. Oncotarget; 2016 Mar 01; 7(9):10322-31. PubMed ID: 26862732 [Abstract] [Full Text] [Related]
13. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer. Leung RC, Liu SS, Chan KY, Tam KF, Chan KL, Wong LC, Ngan HY. Oncol Rep; 2008 May 01; 19(5):1339-45. PubMed ID: 18425396 [Abstract] [Full Text] [Related]
14. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer]. Zhang S, Kong WJ. Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):469-71. PubMed ID: 15555335 [Abstract] [Full Text] [Related]
15. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Ye M, Li D, Zhou F, Guo Q, Xia B. Eur J Cancer Prev; 2012 May 01; 21(3):241-6. PubMed ID: 21979297 [Abstract] [Full Text] [Related]
16. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R. Int J Oncol; 2005 Jun 01; 26(6):1493-500. PubMed ID: 15870861 [Abstract] [Full Text] [Related]
17. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis. Tahara T, Inoue N, Hisamatsu T, Kashiwagi K, Takaishi H, Kanai T, Watanabe M, Ishii H, Hibi T. J Gastroenterol Hepatol; 2005 May 01; 20(5):710-5. PubMed ID: 15853983 [Abstract] [Full Text] [Related]
18. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. Fujii S, Fujimori T, Chiba T. J Exp Clin Cancer Res; 2003 Mar 01; 22(1):107-15. PubMed ID: 12725330 [Abstract] [Full Text] [Related]
19. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M. Carcinogenesis; 2008 Sep 01; 29(9):1845-9. PubMed ID: 18632757 [Abstract] [Full Text] [Related]
20. Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, Hibi T. Cancer Res; 1999 Dec 01; 59(23):5927-31. PubMed ID: 10606237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]